Drug · DIN 02432854
DUAVIVE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 9, 2023; first marketed December 20, 2016.
- Drug Identification Number (DIN)
- 02432854
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Immediate- And Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Conjugated estrogens and bazedoxifene G03CC07
- Class
- Human
- Record last updated
- May 28, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CONJUGATED ESTROGENS | 0.45 MG | |
| BAZEDOXIFENE (BAZEDOXIFENE ACETATE) | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 23, 2014: NOC 16219New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “duavive”. A notice may cover another product or only some lots: read it to see what it covers.
- Duavive (2020-05-20)May 20, 2020 · Drugs · Product safety · Type II